Every round on record, with the sources behind each and the investors on them.
Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers.
cellares.comLinkedInSouth San Francisco, CA
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The $612 million figure is total capital raised, not the Series D amount.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series D [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $257M $612M to date | 2026-01-28 | BlackRock, Eclipse Capital | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The $612 million figure is total capital raised, not the Series D amount. | ||||